The content contained in this podcast was jointly developed by Dr. Robin Dore and Sanofi Genzyme
RA is associated with systemic bone remodeling leading to bone loss. Under normal conditions, proinflammatory cytokines, including IL-6, regulate bone remodeling. However, in patients with RA, IL-6 promotes bone resorption. IL-6 contributes to bone resorption by stimulating RANKL expression and autoantibody production. Visit www.RAandIL6.com to learn more about the broad and important role that IL-6 plays in RA.
Robin K. Dore, MD
Dr. Robin Dore is a rheumatologist in private practice in Tustin, CA and a Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA. She is also certified as a clinical densitometrist by the International Society for Clinical Densitometry. Dr. Dore has been recognized for her contributions to patient and physician education and community service, including on topics such as healthy lifestyles and bone health.